XML 65 R32.htm IDEA: XBRL DOCUMENT

Investments in Joint Ventures and Related Party Transactions (Tables)

12 Months Ended

Dec. 31, 2013

Equity Method Investments And Joint Ventures [Abstract]

Summary of Fair Value of Warrant Liability Using Black-Scholes Option Pricing Model

The fair value of the warrant liability was determined using the Black-Scholes option pricing model based upon the following assumptions as of December 31, 2013 and 2012:


	December 31, 2013			December 31, 2012
Stock price	$	10.89		$	7.75
Exercise price	$	13.50		$	13.50
Expected life in years		7.34			8.34
Risk-free interest rate		2.45	%		1.48	%
Estimated stock volatility		50	%		55	%

Summary of Carrying Amounts of Assets and Fair Value of Liabilities Included in Condensed Consolidated Balance Sheet and Maximum Loss Exposure in VIE

The following table summarizes the carrying amounts of the assets and the fair value of the liabilities included in the Company’s consolidated balance sheet and the maximum loss exposure related to the Company’s interest in its unconsolidated VIE (the Solazyme Bunge JV) as of December 31, 2013 (in thousands):


	Assets						Liabilities
VIE	Accounts Receivable		Unbilled Revenues		Investments in Unconsolidated Joint Ventures		Loan Guarantee		Maximum Exposure to Loss⁽¹⁾
Solazyme Bunge JV	$	6,941	$	1,058	$	22,532	$	0	$	67,702

(1)

Includes maximum exposure to loss attributable to the Company’s bank guarantee required to be provided for the Solazyme Bunge JV of R$35.4 million (approximately $15.0 million based on the exchange rate at December 31, 2013, the Company’s corporate guarantee of approximately $0.9 million (see Note 12) and non-cancellable purchase obligations of R$50.4 million (approximately $21.3 million based on the exchange rate at December 31, 2013).

Summarized Information on Solazyme Bunge JV's Balance Sheets and Income Statements

Summarized information on the Solazyme Bunge JV’s balance sheets and income statements as of December 31, 2013 and 2012 and for the year ended December 31, 2013 and for the period from April 2, 2012 (date of inception) to December 31, 2012, respectively, was as follows (in thousands):


	As of and for the year ended December 31, 2013			As of and for the year ended December 31, 2012
Current assets	$	9,872		$	7,773
Noncurrent assets		127,346			12,765

Total assets	$	137,218		$	20,538

Current liabilities		20,798			3,466
Noncurrent liabilities		90,933			—
JV’s partners’ capital, net		25,487			17,072

Total liabilities and partners’ capital, net	$	137,218		$	20,538

Net sales		—			—
Net losses		(16,280	)		(2,733	)

- Definition

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

+ References+ Details